Molina Healthcare (MOH) EBITDA (2010 - 2026)

Molina Healthcare's EBITDA history runs 17 years deep, the most recent figure standing at $83.0 million for Q1 2026.

• In Q1 2026, EBITDA fell 80.83% year-over-year to $83.0 million; the TTM figure through Mar 2026 stood at $1.1 billion (down 22.93% YoY), while the FY2025 annual figure was $788.0 million, down 54.27% from the prior year.
• EBITDA came in at $83.0 million for Q1 2026 at Molina Healthcare, down from $459.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $459.0 million in Q4 2025 to a low of $11.0 million in Q1 2022.
• A 5-year average of $265.2 million and a median of $338.5 million in 2022 frame the typical range for EBITDA.
• Across the five-year window, EBITDA sank 96.72% in 2022 and soared 4036.36% in 2023, its largest moves.
• Molina Healthcare's EBITDA stood at $49.0 million in 2022, then jumped by 544.9% to $316.0 million in 2023, then rose by 20.25% to $380.0 million in 2024, then gained by 20.79% to $459.0 million in 2025, then tumbled by 81.92% to $83.0 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $83.0 million, $459.0 million, and $137.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison